Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broad-spectrum antibiotic therapy for early stage chronic lymphocytic leukaemia
2010-022260-12Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Mar 2011
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metronidazole, clarithromycin, ciprofloxacin, lansoprazole and omeprazole in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by King's College Hospital. Primary endpoint: Overall response rate at 6 months. Started Mar 2011; status: completed.
02
Drugs
metronidazoleclarithromycinciprofloxacinlansoprazoleomeprazole
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2010-022260-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022260-12.